Key facts
- It has raised $6.5M; the latest was Mezzanine ($2.5M) in Jan 2025.
- Notable investors include US National Science Foundation, U.S. Department of Energy, Business Oregon, Generator Ventures, Oregon Technology Business Center.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Datma
- ·The full record, as it builds
Funding rounds
No funding rounds for Datma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Datma
Developer of a data aggregation and analysis platform designed to focus on precision medicine and related services. The company's platform is focused on the development of the data infrastructure ranging from aggregation, annotation, indexing of genomic, imaging, and other medical data and analysis to develop personalized treatment plans, enabling hospitals, clinics, and health systems to increase operational efficiency and decrease costs by targeting resources.
- Sector
- Information Technology
- HQ
- Beaverton, OR, United States
- Founded
- 2016
- Employees
- 42
- Website
- datma.com/
- Ownership
- Privately Held (backing)
Datma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Datma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Datma in its N-PORT filings yet. We sweep new filings monthly.